Mytheresa, a German online retailer of women's fashions, completed its initial public offering, raising almost $407 million. The company priced its IPO at $26 per share, the top of the range it set. The offering was upsized from $281.64 million.
Morgan Stanley and JPMorgan were the lead managers for the IPO.
The stock trades on the New York Stock Exchange under the ticker symbol "MYTE." Shares of Mytheresa opened at $35.76.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $18.50 |
|---|---|
| 52-week range | $17.29 - $36.25 |
| 50-day moving average | $24.00 |
| 200-day moving average | $27.80 |
| Wall St. target price | $38.58 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.70 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $18.5 from 2022-01-21
| 1 week (2022-01-14) | 2.89% |
|---|---|
| 1 month (2021-12-23) | -14.15% |
| 3 months (2021-10-22) | -32.41% |
| 6 months (2021-07-23) | -38.82% |
| 1 year (2021-01-22) | -45.27% |
|---|---|
| 2 years (2020-01-19) | N/A |
| 3 years (2019-01-19) | N/A |
| 5 years (2017-01-19) | N/A |
Valuing MYT Netherlands Parent B-V stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MYT Netherlands Parent B-V's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MYT Netherlands Parent B-V's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $39.8 million.
The EBITDA is a measure of a MYT Netherlands Parent B-V's overall financial performance and is widely used to measure a its profitability.
To put MYT Netherlands Parent B-V's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $643.6 million |
|---|---|
| Gross profit TTM | $287 million |
| Return on assets TTM | -2.83% |
| Return on equity TTM | -21.15% |
| Profit margin | -7.7% |
| Book value | $4.66 |
| Market capitalisation | $1.5 billion |
TTM: trailing 12 months
We're not expecting MYT Netherlands Parent B-V to pay a dividend over the next 12 months.
You may also wish to consider:
MYT Netherlands Parent B. V. , through its subsidiary, Mytheresa Group GmbH, operates a luxury e-commerce platform for fashion consumers in Germany, the United States, the rest of Europe, and internationally. The company sells clothes, bags, shoes, accessories, and fine jewelry through online and retail stores. It serves high-income luxury consumers. The company was founded in 1987 and is based in Munich, Germany. .
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.